Dermatological experts discuss challenges that are associated with the use of standard and emerging treatments in special patient population.
Eiran Gorodeski, MD, MPH, Parag Goyal, MD, MSc, and James Fang, MD, discuss the HFSA's recent scientific statement on the prevalence and impact of cognitive impairment on the management of heart failure.
Iltefat Hamzavi, MD, explores key areas of patient communication that may shape adherence and outcomes in patients with vitiligo.
Experts in dermatology share advice on helping fellow physicians stay apprised of the advances in AD and treat their patients more effectively.
A history of bariatric surgery was associated with up to 50% reduced risk of PDAC among a national cohort.
Steve Harvey, MD, discusses the challenges of defining treatment resistant depression and provides and overview of treatment options.
Clinical pearls regarding the management of patients with atopic dermatitis with newer treatment approaches as the field continues to evolve.
Concluding their discussion on sickle cell disease management, expert panelists share key unmet needs and hopes for the future.
A history of bariatric surgery was associated with up to 50% reduced risk of PDAC among a national cohort.
Mark Barakat, MD, reviews the best practices for patient communication and shared decision making.
The panel offers their final recommendations for physicians managing patients with asthma.
Veeral Sheth, MD, MBA discusses the 3 improvements needed for the future of treating patients with geographic atrophy.
Iltefat Hamzavi, MD, explores key areas of patient communication that may shape adherence and outcomes in patients with vitiligo.
Andrew Wang, MD; James Januzzi, MD; Michelle M. Kittleson, MD, PhD; and Milind Desai, MD, MBA, share a look into the future of oHCM treatment.
Nehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.
Experts in gastroenterology discuss treatment selection in special situations of CD, such as age, women considering pregnancy, and extra-intestinal manifestations.
Alexa Hetzel, MA, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, PA, share practice pearls and clinical management tips for the care of pediatric patients with atopic dermatitis.
Shawn Kwatra, MD, and Sarina B. Elmariah, MD, PhD, share final pearls of wisdom for other physicians taking care of patients with prurigo nodularis (PN).
The Contemporary Pediatrics Editor-in-Chief reviews the pharmacological breakthroughs and epidemiological setbacks that defined RSV in 2023.
Drs Rakesh Jain, Greg Mattingly, David W. Goodman, Birgit H. Amann, and Theresa R. Cerulli, discuss emerging agents in the pipeline for the management of pediatric and adult ADHD.
Dr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.
A follow-up to an earlier episode, this episode features a deep dive into the hosts experience with the Dexcom Stelo sensor.
What pharmacists and providers need to know to counsel patients on when discussing the use of prescription or over-the-counter fish oil supplement as treatment for dyslipidemia and hypertriglyceridemia.
Leon Kircik, MD, shares his impressions of the long-term data of roflumilast, and where it fits into clinical practice.